Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect in USD of China Health Industries Holdings, Inc. from 2021 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
China Health Industries Holdings, Inc. quarterly/annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect history and change rate from 2021 to Q3 2023.
  • China Health Industries Holdings, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending 30 Sep 2023 was -$34.8K, a 98.7% increase year-over-year.
  • China Health Industries Holdings, Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2023 was -$44.7M, a 10194% decline from 2022.
  • China Health Industries Holdings, Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2022 was $443K, a 94.6% decline from 2021.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Quarterly Change (%)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Annual (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Annual Change (%)

China Health Industries Holdings, Inc. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$34.8K +$2.64M +98.7% 01 Jul 2023 30 Sep 2023 10-Q 21 Nov 2023
Q3 2022 -$2.67M -$4.26M -267% 01 Jul 2022 30 Sep 2022 10-Q 21 Nov 2023
Q3 2021 $1.59M 01 Jul 2021 30 Sep 2021 10-Q 04 Nov 2022

China Health Industries Holdings, Inc. Annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$44.7M -$45.2M -10194% 01 Jul 2022 30 Jun 2023 10-K 13 Nov 2023
2022 $443K -$7.83M -94.6% 01 Jul 2021 30 Jun 2022 10-K 13 Nov 2023
2021 $8.27M 01 Jul 2020 30 Jun 2021 10-K/A 10 Apr 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.